Newton, MA, United States of America

Timothy Alan Springer

USPTO Granted Patents = 45 

 

 

Average Co-Inventor Count = 2.7

ph-index = 13

Forward Citations = 689(Granted Patents)


Location History:

  • Newtown, MA (US) (1995)
  • Boston, MA (US) (2017)
  • Newton, MA (US) (1990 - 2021)
  • Chestnut Hill, MA (US) (1991 - 2021)

Company Filing History:


Years Active: 1990-2021

Loading Chart...
Loading Chart...
Loading Chart...
45 patents (USPTO):Explore Patents

Title: **Timothy Alan Springer: A Pioneer in Biotechnology and Patent Innovation**

Introduction

Timothy Alan Springer, located in Newton, MA, is a renowned inventor and researcher in the field of biotechnology. With an impressive portfolio of 45 patents, his work primarily focuses on the modulation of biological responses, particularly in the context of immunology and cancer treatment. His contributions have significantly advanced the understanding and treatment options available for various medical conditions.

Latest Patents

Among his recent patents, two stand out for their innovative approaches. The first patent discusses "Methods and compositions for modulation of transforming growth factor beta-regulated functions," which reveals compositions and methods aimed at modulating the activity of TGF-β. This includes techniques for modulating the release of active TGF-β from an LRRC33-TGF-β prodomain-TGF-β ternary complex, providing new avenues for treatment strategies.

Another significant patent involves "Modified integrin polypeptides, modified integrin polypeptide dimers, and uses thereof." This patent describes modified integrin α and/or β headpiece polypeptides, along with crystallizable integrin polypeptide dimers. The methods outlined for characterizing integrin-ligand interactions are expected to lead to the identification of integrin ligands that could serve as inhibitors of integrins, furthering therapeutic possibilities in various diseases.

Career Highlights

Timothy Alan Springer has made notable contributions while affiliated with institutions like the Dana-Farber Cancer Institute and the Center for Blood Research. His research has not only enhanced scientific knowledge but also influenced therapeutic methodologies in treating complex diseases such as cancer.

Collaborations

Throughout his career, Springer has collaborated with prominent researchers such as Michael L. Dustin and Chafen Lu. These partnerships have facilitated a deeper exploration of biological systems and the development of innovative treatments based on his patented inventions.

Conclusion

In conclusion, Timothy Alan Springer’s extensive patent portfolio and collaborative efforts have positioned him as a leading figure in the biotechnology sector. His innovative approaches to modulating biological functions continue to pave the way for advancements in medical research and treatment options, impacting the lives of many.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…